1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter

Hicham Drissi, Arlyssa Pouliot, Christian Koolloos, Janet L. Stein, Jane B. Lian, Gary S. Stein, Andre J van Wijnen

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

The steroid hormone 1,25-(OH)2-vitamin D3 (VD3) regulates osteoblast differentiation by either activating or repressing transcription of numerous bone phenotypic genes. We addressed whether VD3 also influences osteogenesis by controlling activity of the runt-related transcription factor Runx2/Cbfa1, a key regulator of bone formation in vivo. Our data showed that expression of Runx2 was downregulated by VD3 within 24 h in MC3T3 and ROS 17/2.8, but not in ROS 24.1 cells, which lack a functional vitamin D receptor (VDR). Transient transfection assays showed that the initial 0.6 kb of the bone-related rat and mouse Runx2 promoters both exhibited a 50% reduction of promoter activity in response to VD3 in osteoblastic cells. Furthermore, VD3 inhibited Runx2 transcription in ROS 24.1 cells only upon forced expression of the VDR. Gel mobility shift assays with antibodies and oligonucleotide competition experiments demonstrated that proximal promoter sequences (-92 to -16) contain a functional VD3-responsive element (VDRE) that binds a VDR/retinoid X receptor heterodimer. Mutation of this VDRE completely abolished responsiveness of the Runx2 promoter to VD3 treatment. Together these studies establish that Runx2 expression is regulated by VD3. This VD3-mediated suppression of Runx2 activity provides regulatory coupling between tissue-specific and steroid hormone-dependent control of genes during bone formation.

Original languageEnglish (US)
Pages (from-to)323-333
Number of pages11
JournalExperimental Cell Research
Volume274
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Cholecalciferol
Bone and Bones
Genes
Calcitriol Receptors
Osteogenesis
Steroids
Hormones
Retinoid X Receptors
Electrophoretic Mobility Shift Assay
Osteoblasts
Oligonucleotides
Transfection
Transcription Factors
Down-Regulation
Gels
Mutation
Antibodies

Keywords

  • 1,25-(OH)-vitamin D3
  • Gene expression
  • Osteoblast
  • Promoter
  • Runx2/Cbfa1
  • Transcription

ASJC Scopus subject areas

  • Cell Biology

Cite this

Drissi, H., Pouliot, A., Koolloos, C., Stein, J. L., Lian, J. B., Stein, G. S., & van Wijnen, A. J. (2002). 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Experimental Cell Research, 274(2), 323-333. https://doi.org/10.1006/excr.2002.5474

1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. / Drissi, Hicham; Pouliot, Arlyssa; Koolloos, Christian; Stein, Janet L.; Lian, Jane B.; Stein, Gary S.; van Wijnen, Andre J.

In: Experimental Cell Research, Vol. 274, No. 2, 2002, p. 323-333.

Research output: Contribution to journalArticle

Drissi, H, Pouliot, A, Koolloos, C, Stein, JL, Lian, JB, Stein, GS & van Wijnen, AJ 2002, '1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter', Experimental Cell Research, vol. 274, no. 2, pp. 323-333. https://doi.org/10.1006/excr.2002.5474
Drissi H, Pouliot A, Koolloos C, Stein JL, Lian JB, Stein GS et al. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Experimental Cell Research. 2002;274(2):323-333. https://doi.org/10.1006/excr.2002.5474
Drissi, Hicham ; Pouliot, Arlyssa ; Koolloos, Christian ; Stein, Janet L. ; Lian, Jane B. ; Stein, Gary S. ; van Wijnen, Andre J. / 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. In: Experimental Cell Research. 2002 ; Vol. 274, No. 2. pp. 323-333.
@article{f3fe03675d274e48a358a4f769abed13,
title = "1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter",
abstract = "The steroid hormone 1,25-(OH)2-vitamin D3 (VD3) regulates osteoblast differentiation by either activating or repressing transcription of numerous bone phenotypic genes. We addressed whether VD3 also influences osteogenesis by controlling activity of the runt-related transcription factor Runx2/Cbfa1, a key regulator of bone formation in vivo. Our data showed that expression of Runx2 was downregulated by VD3 within 24 h in MC3T3 and ROS 17/2.8, but not in ROS 24.1 cells, which lack a functional vitamin D receptor (VDR). Transient transfection assays showed that the initial 0.6 kb of the bone-related rat and mouse Runx2 promoters both exhibited a 50{\%} reduction of promoter activity in response to VD3 in osteoblastic cells. Furthermore, VD3 inhibited Runx2 transcription in ROS 24.1 cells only upon forced expression of the VDR. Gel mobility shift assays with antibodies and oligonucleotide competition experiments demonstrated that proximal promoter sequences (-92 to -16) contain a functional VD3-responsive element (VDRE) that binds a VDR/retinoid X receptor heterodimer. Mutation of this VDRE completely abolished responsiveness of the Runx2 promoter to VD3 treatment. Together these studies establish that Runx2 expression is regulated by VD3. This VD3-mediated suppression of Runx2 activity provides regulatory coupling between tissue-specific and steroid hormone-dependent control of genes during bone formation.",
keywords = "1,25-(OH)-vitamin D3, Gene expression, Osteoblast, Promoter, Runx2/Cbfa1, Transcription",
author = "Hicham Drissi and Arlyssa Pouliot and Christian Koolloos and Stein, {Janet L.} and Lian, {Jane B.} and Stein, {Gary S.} and {van Wijnen}, {Andre J}",
year = "2002",
doi = "10.1006/excr.2002.5474",
language = "English (US)",
volume = "274",
pages = "323--333",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter

AU - Drissi, Hicham

AU - Pouliot, Arlyssa

AU - Koolloos, Christian

AU - Stein, Janet L.

AU - Lian, Jane B.

AU - Stein, Gary S.

AU - van Wijnen, Andre J

PY - 2002

Y1 - 2002

N2 - The steroid hormone 1,25-(OH)2-vitamin D3 (VD3) regulates osteoblast differentiation by either activating or repressing transcription of numerous bone phenotypic genes. We addressed whether VD3 also influences osteogenesis by controlling activity of the runt-related transcription factor Runx2/Cbfa1, a key regulator of bone formation in vivo. Our data showed that expression of Runx2 was downregulated by VD3 within 24 h in MC3T3 and ROS 17/2.8, but not in ROS 24.1 cells, which lack a functional vitamin D receptor (VDR). Transient transfection assays showed that the initial 0.6 kb of the bone-related rat and mouse Runx2 promoters both exhibited a 50% reduction of promoter activity in response to VD3 in osteoblastic cells. Furthermore, VD3 inhibited Runx2 transcription in ROS 24.1 cells only upon forced expression of the VDR. Gel mobility shift assays with antibodies and oligonucleotide competition experiments demonstrated that proximal promoter sequences (-92 to -16) contain a functional VD3-responsive element (VDRE) that binds a VDR/retinoid X receptor heterodimer. Mutation of this VDRE completely abolished responsiveness of the Runx2 promoter to VD3 treatment. Together these studies establish that Runx2 expression is regulated by VD3. This VD3-mediated suppression of Runx2 activity provides regulatory coupling between tissue-specific and steroid hormone-dependent control of genes during bone formation.

AB - The steroid hormone 1,25-(OH)2-vitamin D3 (VD3) regulates osteoblast differentiation by either activating or repressing transcription of numerous bone phenotypic genes. We addressed whether VD3 also influences osteogenesis by controlling activity of the runt-related transcription factor Runx2/Cbfa1, a key regulator of bone formation in vivo. Our data showed that expression of Runx2 was downregulated by VD3 within 24 h in MC3T3 and ROS 17/2.8, but not in ROS 24.1 cells, which lack a functional vitamin D receptor (VDR). Transient transfection assays showed that the initial 0.6 kb of the bone-related rat and mouse Runx2 promoters both exhibited a 50% reduction of promoter activity in response to VD3 in osteoblastic cells. Furthermore, VD3 inhibited Runx2 transcription in ROS 24.1 cells only upon forced expression of the VDR. Gel mobility shift assays with antibodies and oligonucleotide competition experiments demonstrated that proximal promoter sequences (-92 to -16) contain a functional VD3-responsive element (VDRE) that binds a VDR/retinoid X receptor heterodimer. Mutation of this VDRE completely abolished responsiveness of the Runx2 promoter to VD3 treatment. Together these studies establish that Runx2 expression is regulated by VD3. This VD3-mediated suppression of Runx2 activity provides regulatory coupling between tissue-specific and steroid hormone-dependent control of genes during bone formation.

KW - 1,25-(OH)-vitamin D3

KW - Gene expression

KW - Osteoblast

KW - Promoter

KW - Runx2/Cbfa1

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=0036343579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036343579&partnerID=8YFLogxK

U2 - 10.1006/excr.2002.5474

DO - 10.1006/excr.2002.5474

M3 - Article

C2 - 11900492

AN - SCOPUS:0036343579

VL - 274

SP - 323

EP - 333

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -